SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda

Ekso Bionics: Fragile Opportunity

04:34am, Wednesday, 24'th Aug 2022
Ekso Bionics has added a new use case for the EksoNR exoskeleton, multiple sclerosis, opening some new avenues for marginal revenue growth. Pre-Covid, Ekso had started to see sharp improvements in ope
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2022 Results Conference Call July 28, 2022 4:30 PM ET Company Participants David Carey - Head, Investor Relations Steven Sherman - Chairman & CEO Scott Da
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today a
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W

Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates

09:35pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Ekso Bionics Reports First Quarter 2022 Results

08:05pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SARTORIUS (SARTF) Tops Q1 Earnings and Revenue Estimates

02:25pm, Thursday, 21'st Apr 2022 Zacks Investment Research
SARTORIUS (SARTF) delivered earnings and revenue surprises of 10.04% and 8.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

12:03pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

11:00pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE